The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence
Abstract
Summary: Measurement of the thrombin generating potential could provide a method for quantifying the composite effect of multiple risk factors. This study assessed the risk of a first as well as a recurrent venous thrombotic event associated with an increased endogenous thrombin potential (ETP). Analyses were performed in 360 patients and 404 control subjects of the Leiden Thrombophilia Study. The ETP was measured directly using a fluorogenic assay (Thrombinoscope TM). Individuals with an increased ETP, i.e. above 90th percentile measured in control subjects (>2109·0 nM·min) had a 1·5‐fold [95% confidence interval (CI): 0·9–2·3] increased risk of a first deep venous thrombosis. The risk was more pronounced after the analysis was restricted to idiopathic thromboses, i.e. 1·7‐fold (95% CI: 1·0–2·8). Overall, the hazard ratio of a recurrent thrombotic event associated with a high ETP, adjusted for age, sex and oral anticoagulant use was 1·1 (95% CI: 0·5–2·2). Thus, a high ETP was not associated with an increased relative risk of recurrent venous thrombosis. At present, the clinical relevance of the thrombin generation assay in predicting recurrent venous thrombosis remains uncertain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
High plasma levels of factor VIII and the risk of recurrent venous thromboembolism
Kyrle, P. A., Minar, E., Hirschl, M., Bialonczyk, C., Stain, M., Schneider, B., Weltermann, A., Speiser, W., Lechner, K., & Eichinger, S. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008173430702 · Cited by 763 · cited 1×
“…by (Ho et al, 2006), elevated TAFI levels (Eichinger et al, 2004), low vitamin B6 (Eichinger, 2006), low free TFPI (Hoke et al, 2005), hyperhomocysteinemia (Keijzer et al, 2002; Eichinger, 2003) and elevated levels of factor VIII and IX (Kyrle et al, 2000; Weltermann et al, 2003; Bobrow, 2005).”
BackgroundBaglin, T., Luddington, R., Brown, K., & Baglin, C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14111-6 · Cited by 694
Self-citationd -Dimer Testing to Determine the Duration of Anticoagulation Therapy
Palareti, G., Cosmi, B., Legnani, C., Tosetto, A., Brusi, C., Iorio, A., Pengo, V., Ghirarduzzi, A., Pattacini, C., Testa, S., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054444 · Cited by 622
Cited by
Wolberg, A. S., Rosendaal, F. R., Weitz, J. I., Jaffer, I. H., Agnelli, G., Baglin, T., & Mackman, N. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.6 · Cited by 369
Self-citationThrombin Generation Assay and Its Application in the Clinical Laboratory
Tripodi, A. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2015.248625 · Cited by 318
Malin Nylander, S. F. (2015) · Journal of Obesity & Weight Loss Therapy · doi:10.4172/2165-7904.1000254 · Cited by 7
Metadata
- Authors
- Van Hylckama Vlieg, A., Christiansen, S. C., Luddington, R., Cannegieter, S. C., Rosendaal, F. R., & Baglin, T. P.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 2007-08-23
- Volume
- 138
- Issue
- 6
- Pages
- 769-774
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W1970393874
- Cited by
- 171
- References
- 3
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence. https://app.cochat.ai/papers/10.1111/j.1365-2141.2007.06738.x
- The paper
- Van Hylckama Vlieg, A., Christiansen, S. C., Luddington, R., Cannegieter, S. C., Rosendaal, F. R., & Baglin, T. P. (2007). Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence. British Journal of Haematology. https://doi.org/10.1111/j.1365-2141.2007.06738.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.